Group One Trading
ADIL

Group One Trading’s Adial Pharmaceuticals ADIL Stock Holding History

Group One Trading’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed -$1K – 7460
2022
Q2 		$1K Hold
1
– – ﹤0.01% 7500
2022
Q1 		$2K Sell
1
-5
-83% -$6.85K ﹤0.01% 7695
2021
Q4 		$10K Buy
+6
New +$11.8K ﹤0.01% 7334

Other funds holding ADIL

MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Group One Trading's ADIL Position: Q1 2023 in Review

Group One Trading held its Adial Pharmaceuticals (ADIL) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7123.

Group One Trading first reported a position in ADIL in Q4 2021 and has held it in 4 quarters since. The position peaked at $27K in Q1 2022. 22 funds tracked by Wall St. Rank hold ADIL as of Q1 2023.

  • Group One Trading held 0 shares of Adial Pharmaceuticals worth $0 as of Q1 2023.
  • Group One Trading left its Adial Pharmaceuticals share count unchanged in Q1 2023.
  • Adial Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2023, its #7123 holding.
  • Group One Trading first reported a position in Adial Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • Group One Trading's Adial Pharmaceuticals position peaked at $27K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.